ruxolitinib,navitoclax
incyte,abbvie,Novartis
['ruxolitinib', '#mf ', 'navitoclax', 'refine study', '#myelof', 'rux,(-crux),(-trux)', 'rux,(-crux),(-trux),(-deruxtecan)']
in an ongoing study, researchers evaluated the efficacy and safety of adding bcl-xl/bcl-2 inhibitor navitoclax to #ruxolitinib therapy (nav+rux) from cohort 3 of the phase ii #refine study in jaki-na ve #mf patients: #ash22 #myelofibrosis #hemonc 
Reporting essential clinical news w/ independent analysis for cancer care professionals to optimize patient care & outcomes; oncology/hematology